A whole organism small molecule screen identifies novel regulators of pancreatic endocrine development.


Journal

Development (Cambridge, England)
ISSN: 1477-9129
Titre abrégé: Development
Pays: England
ID NLM: 8701744

Informations de publication

Date de publication:
24 07 2019
Historique:
received: 08 10 2018
accepted: 08 05 2019
pubmed: 31 5 2019
medline: 7 7 2020
entrez: 31 5 2019
Statut: epublish

Résumé

An early step in pancreas development is marked by the expression of the transcription factor Pdx1 within the pancreatic endoderm, where it is required for the specification of all endocrine cell types. Subsequently, Pdx1 expression becomes restricted to the β-cell lineage, where it plays a central role in β-cell function. This pivotal role of Pdx1 at various stages of pancreas development makes it an attractive target to enhance pancreatic β-cell differentiation and increase β-cell function. In this study, we used a newly generated zebrafish reporter to screen over 8000 small molecules for modulators of

Identifiants

pubmed: 31142539
pii: dev.172569
doi: 10.1242/dev.172569
pmc: PMC6679364
pii:
doi:

Substances chimiques

Histone Deacetylase Inhibitors 0
Homeodomain Proteins 0
Small Molecule Libraries 0
Trans-Activators 0
pancreatic and duodenal homeobox 1 protein 0
Valproic Acid 614OI1Z5WI

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIDDK NIH HHS
ID : U01 DK105541
Pays : United States

Informations de copyright

© 2019. Published by The Company of Biologists Ltd.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare no competing or financial interests.

Références

J Clin Invest. 1999 Nov;104(9):R41-8
pubmed: 10545531
J Endocrinol. 1999 Dec;163(3):523-30
pubmed: 10588826
Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7260-5
pubmed: 10860991
N Engl J Med. 2001 Sep 27;345(13):971-80
pubmed: 11575290
Epilepsy Res. 2002 Jan;48(1-2):91-102
pubmed: 11823113
Nature. 2003 Mar 13;422(6928):173-6
pubmed: 12629551
J Clin Invest. 2003 Apr;111(8):1147-60
pubmed: 12697734
Dev Dyn. 2003 Jul;227(3):347-56
pubmed: 12815620
J Biol Chem. 2004 Dec 3;279(49):51218-25
pubmed: 15364908
Transplantation. 2004 Nov 15;78(9):1367-75
pubmed: 15548977
Diabetes. 2004 Dec;53 Suppl 3:S16-21
pubmed: 15561905
Dev Biol. 2005 Oct 1;286(1):225-37
pubmed: 16126192
Mol Cell. 2006 Aug;23(4):607-18
pubmed: 16916647
Development. 2006 Oct;133(20):4063-72
pubmed: 17008449
Mech Dev. 2007 Mar;124(3):218-29
pubmed: 17223324
Diabetologia. 2007 Apr;50(4):779-89
pubmed: 17265033
Nat Protoc. 2008;3(1):59-69
pubmed: 18193022
J Neurosci. 2008 Feb 27;28(9):2110-8
pubmed: 18305245
Dev Biol. 2008 May 15;317(2):467-79
pubmed: 18394596
Dev Biol. 2008 Oct 15;322(2):237-50
pubmed: 18687323
Mol Cell Endocrinol. 2008 Nov 6;294(1-2):1-9
pubmed: 18687378
Cell Cycle. 2009 Feb 15;8(4):536-44
pubmed: 19197155
Mech Dev. 2009 Oct;126(10):898-912
pubmed: 19595765
Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14896-901
pubmed: 19706417
Science. 2010 Feb 19;327(5968):1000-4
pubmed: 20167786
Nature. 2010 Apr 22;464(7292):1149-54
pubmed: 20364121
Nat Methods. 2011 May;8(5):424-9
pubmed: 21478862
Curr Biol. 2011 Apr 26;21(8):712-7
pubmed: 21497092
Genes Dev. 2011 Aug 15;25(16):1680-5
pubmed: 21852533
Development. 2011 Oct;138(19):4327-32
pubmed: 21865323
Development. 2012 May;139(9):1557-67
pubmed: 22492351
Cell Metab. 2012 Jun 6;15(6):885-94
pubmed: 22608007
Essays Biochem. 2012;52:23-35
pubmed: 22708561
Nat Chem Biol. 2013 Feb;9(2):97-104
pubmed: 23201900
Ann N Y Acad Sci. 2013 Apr;1281:92-105
pubmed: 23363033
Development. 2013 Jul;140(13):2776-86
pubmed: 23698350
Development. 2013 Jul;140(13):2669-79
pubmed: 23720049
Curr Biol. 2013 Jul 8;23(13):1242-50
pubmed: 23791726
Drug Discov Today. 2013 Dec;18(23-24):1301-8
pubmed: 24051395
PLoS Genet. 2013 Oct;9(10):e1003934
pubmed: 24204325
J Clin Invest. 2014 Jan;124(1):30-9
pubmed: 24382387
Cell Metab. 2014 Feb 4;19(2):259-71
pubmed: 24506867
Cold Spring Harb Perspect Biol. 2014 Apr 01;6(4):a018713
pubmed: 24691964
PLoS One. 2014 Aug 12;9(8):e104112
pubmed: 25117518
Nat Biotechnol. 2014 Nov;32(11):1121-33
pubmed: 25211370
Elife. 2014 Sep 16;3:e02809
pubmed: 25233132
Cell. 2014 Oct 9;159(2):428-39
pubmed: 25303535
Dev Dyn. 2015 Jun;244(6):724-35
pubmed: 25773748
Development. 2015 Apr 15;142(8):1407-17
pubmed: 25852199
EMBO J. 2015 Jul 2;34(13):1759-72
pubmed: 25908839
Nat Rev Drug Discov. 2015 Oct;14(10):721-31
pubmed: 26361349
J Mol Endocrinol. 2015 Dec;55(3):197-207
pubmed: 26373795
Sci Rep. 2015 Sep 18;5:14241
pubmed: 26384018
PLoS One. 2016 Feb 22;11(2):e0149497
pubmed: 26900852
Biochim Biophys Acta. 2016 Oct;1864(10):1372-401
pubmed: 27296530
EMBO J. 2016 Sep 15;35(18):2026-44
pubmed: 27516442
Oncotarget. 2016 Sep 6;7(36):57485-57497
pubmed: 27542279
Cell. 2017 Jan 12;168(1-2):73-85.e11
pubmed: 27916274
Cell. 2017 Jan 12;168(1-2):86-100.e15
pubmed: 27916275
Mol Metab. 2016 Nov 22;6(1):30-37
pubmed: 28123935
Diabetes Obes Metab. 2017 Jul;19(7):936-943
pubmed: 28155245
BMC Biol. 2017 Mar 21;15(1):21
pubmed: 28327131
Physiol Rev. 2017 Jul 1;97(3):889-938
pubmed: 28468832
Cell Metab. 2018 Jan 9;27(1):218-225.e4
pubmed: 29103923
J Mol Cell Cardiol. 2018 Jan;114:309-319
pubmed: 29224834
Sci Rep. 2018 Mar 8;8(1):4199
pubmed: 29520020
Cell Metab. 2018 Nov 6;28(5):787-792.e3
pubmed: 30057067
Elife. 2018 Dec 06;7:
pubmed: 30520733
EMBO J. 1993 Nov;12(11):4251-9
pubmed: 7901001
Nature. 1994 Oct 13;371(6498):606-9
pubmed: 7935793
Dev Dyn. 1995 Jul;203(3):253-310
pubmed: 8589427
Development. 1996 Mar;122(3):983-95
pubmed: 8631275
Endocrinology. 1998 Mar;139(3):1440-9
pubmed: 9492081
Genes Dev. 1998 Jun 15;12(12):1763-8
pubmed: 9637677

Auteurs

Christian S M Helker (CSM)

Max Planck Institute for Heart and Lung Research, Department of Developmental Genetics, 61231 Bad Nauheim, Germany Christian.Helker@mpi-bn.mpg.de Didier.Stainier@mpi-bn.mpg.de.
Philipps-University Marburg, Faculty of Biology, Cell Signaling and Dynamics, 35043 Marburg, Germany.

Sri-Teja Mullapudi (ST)

Max Planck Institute for Heart and Lung Research, Department of Developmental Genetics, 61231 Bad Nauheim, Germany.

Laura M Mueller (LM)

Centre for Stem Cells and Regenerative Medicine, King's College London, London WC2R 2LS, UK.

Jens Preussner (J)

Max Planck Institute for Heart and Lung Research, ECCPS Bioinformatics Core Unit, 61231 Bad Nauheim, Germany.

Sorin Tunaru (S)

Max Planck Institute for Heart and Lung Research, Department of Pharmacology, 61231 Bad Nauheim, Germany.
Biochemistry Institute of the Romanian Academy, Department of Enzymology, Bucharest 060031, Romania.

Oskar Skog (O)

Uppsala University, Department of Immunology, Genetics and Pathology, 751 85 Uppsala, Sweden.

Hyouk-Bum Kwon (HB)

Max Planck Institute for Heart and Lung Research, Department of Developmental Genetics, 61231 Bad Nauheim, Germany.

Florian Kreuder (F)

Max Planck Institute for Heart and Lung Research, Department of Developmental Genetics, 61231 Bad Nauheim, Germany.

Joseph J Lancman (JJ)

Human Genetics Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
Graduate School of Biomedical Sciences, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.

Remy Bonnavion (R)

Max Planck Institute for Heart and Lung Research, Department of Pharmacology, 61231 Bad Nauheim, Germany.

P Duc Si Dong (PDS)

Human Genetics Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
Graduate School of Biomedical Sciences, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.

Mario Looso (M)

Max Planck Institute for Heart and Lung Research, ECCPS Bioinformatics Core Unit, 61231 Bad Nauheim, Germany.

Stefan Offermanns (S)

Max Planck Institute for Heart and Lung Research, Department of Pharmacology, 61231 Bad Nauheim, Germany.

Ole Korsgren (O)

Uppsala University, Department of Immunology, Genetics and Pathology, 751 85 Uppsala, Sweden.

Francesca M Spagnoli (FM)

Centre for Stem Cells and Regenerative Medicine, King's College London, London WC2R 2LS, UK.

Didier Y R Stainier (DYR)

Max Planck Institute for Heart and Lung Research, Department of Developmental Genetics, 61231 Bad Nauheim, Germany Christian.Helker@mpi-bn.mpg.de Didier.Stainier@mpi-bn.mpg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH